b RAS G12, G13 or Q61 mut or no RAS mut identified. This is an ASCO Meeting Abstract from the 2026 ASCO Annual Meeting II. This abstract does not include a full text component.
At the moment, RevMed remains keenly focused on its mission to bring daraxonrasib to the masses and continue developing new medicines that target RAS. (Darren Incorvaia) This year’s meeting of the ...
In one of the most far-reaching changes to Pakistan's higher education admission system in recent years, Higher Education Commission Pakistan has centralised the MPhil and PhD admission process by ...
The Higher Education Commission of Pakistan (HEC) on Monday announced the launch of a “fully online and paperless” degree attestation system to facilitate students. In December last year, the HEC said ...
AACR was full of biotechs showcasing their preclinical Ras candidates, including Clasp Therapeutics, Verastem Oncology and BlossomHill Therapeutics. (Darren Incorvaia) After dropping headline-grabbing ...
Qatar has said Iranian missile attacks on the Ras Laffan Industrial City, the country’s main gas facility, have caused “significant damage”. “The State of Qatar expresses its strong condemnation and ...
DOHA, March 18: The Ministry of Defense of Qatar announced that the country was targeted by five ballistic missiles launched from Iran on Wednesday. According to the ministry, Qatari air defence ...
Saudi Arabia's national oil company said its Ras Tanura refinery was restarting as it outlined plans to boost shareholder payouts including raising its quarterly base dividend by 3.5%. Volkswagen ...
PARIS — RAS Luxury Skincare, the Indian farm-to-face brand, closed a 65 Crores, or $7.5 million, Series B funding round led by Dabur Ventures. Dabur Ventures is the venture arm of the largest ...
RAS Luxury Skincare has raised $7.5 Mn (about ₹68.7 Cr) in its Series B funding round led by Dabur Ventures, with participation from existing investor Unilever Ventures The fresh capital will be used ...
NEW YORK--(BUSINESS WIRE)--TJC LP (“TJC” or “the Firm”), a middle-market private equity firm investing primarily in North America, today announced that the Firm earned the #4 ranking on the HEC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results